Objective: To investigate the effect of placental pathology on neonatal neutrophils, platelets, hematocrit and nucleated red blood cells in very low birthweight (VLBW) infants born to mothers with preeclampsia.
Introduction
Preeclampsia is a common disorder of pregnancy affecting nearly 5 to 8% of pregnant women annually in the United States. The NIH reported in 2000 that preeclampsia had risen by one-third over the previous decade.
1 Preeclampsia is known to be a common cause of neonatal neutropenia and thrombocytopenia. It has previously been postulated that both neonatal neutropenia and thrombocytopenia result from decreased production of WBCs and platelets (Plt) from placental insufficiency. [2] [3] [4] [5] [6] [7] [8] [9] Preeclampsia is also known to have associated placental pathology. 10 Different placental histopathologies are associated with specific clinical features of preterm preeclampsia. Severe maternal proteinuria is related to placental chronic inflammation, whereas lower maternal antepartum Plt counts are related to placental abruption and infarction. Lower birthweight percentiles and lighter placentas are directly associated with uteroplacental vascular lesions. 11 To date, the link between different placental pathological conditions associated with preeclampsia, neonatal neutropenia and thrombocytopenia have not been explored. In this study, we hypothesized that there would be specific placental findings associated with neonatal hematologic abnormalities in infants born to mothers with preeclampsia.
The purpose of this study was to investigate the association between placental pathology and neonatal absolute neutrophil count (ANC), Plt, hematocrit (Hct) and nucleated red blood cells (NRBC) in very low birthweight (VLBW) infants born to mothers with preeclampsia.
Methods
The study was a retrospective nested-cohort study of VLBW infants (<1500 gm) born to mothers with preeclampsia at Christiana Care Health System. Christiana Care Health System is the single level III regional neonatal intensive care unit serving the state of Delaware. The study sample included inborn infants cared for between July 2002 and July 2006. The study sample included only infants born to mothers with preeclampsia. The Institutional Board Review at Christiana Care Health Services approved this project.
The diagnosis of preeclampsia was made by the attending obstetrician based on ACOG guidelines of elevated blood pressure (>140 systolic or >90 diastolic) and proteinuria (>0.3gm of protein in a 24 h urine collection) after 20 weeks of gestation. 12 For the purposes of this study, estimated gestational age was defined by best obstetric estimate. Small for gestational age (SGA) was defined as birthweight of <10%. Data on prenatal steroid administration were collected and mothers were classified as receiving antenatal steroids if they received a minimum of 1 dose of betamethasone or dexamethasone before the delivery.
Clinical pathology reports were obtained on all infants. The decision to send the placenta for pathologic evaluation was made by the attending obstetrician. The placentas were examined by one of nine attending pathologists at Christiana Care Health System who were blinded to the clinical and hematologic outcomes of the infants. Christiana Care Health System evaluates approximately 1500 placentas per year of the 7000 live births. The placentas were systematically reviewed according to the Placental Pathology Practice Guideline Development Task Force. 13 These guidelines attempt to create uniformity for analysis of the placenta, which is a relatively subjective process. The reports were reviewed for placental abnormalities using standard definitions for commonly described placental lesions. 14 The guidelines encourage the reporting of the most significant lesions such as presence of chorioamnionitis, villitis, central infarcts (rather than marginal infarcts) and vasculopathy and discourage reporting minor findings. Those born to mothers with preeclampsia who did not have a placental pathology report were excluded from this study.
Infants in the study sample had complete blood counts drawn as per neonatal intensive care unit protocol. This included a complete blood counts on admission and the first two days of life. Complete blood counts were obtained more frequently as clinically indicated. Hematologic parameters investigated included ANC, Plt count, Hct and total NRBC's. All complete blood counts were analyzed in standard fashion using a Sysmex Model Xe2100 Coulter Counter (Hialiah, FL, USA). Total NRBCs were calculated by multiplying the total WBC count by the number of NRBC counted per 100 WBC.
Thrombocytopenia was defined as Plt count less than 100 K/ mm 3 . 15 Neutropenia was defined by the Mouzhino criteria: ANC less than 500 on day of life 0, ANC less than 2000 on day of life 1, and ANC less than 1100 on day of life 2.
16
Statistics Statistical analysis included both univariable and multivariable analysis. Univariable analysis included w 2 -test, MannFWhitney test, U-test, ANOVA (analysis of variance), and repeated measures ANOVA as appropriate. Multivariable analysis includes logistic regression. A P-value < 0.05 was considered significant; all data are expressed as mean±s.d.
Results
During the study period, 211 inborn infants were born to mothers with preeclampsia. The final study sample included 203 infants; 8 infants born to mothers with preeclampsia were excluded, as they did not have placental pathology results. In the study sample, 30 infants were diagnosed with neutropenia and 48 infants with thrombocytopenia during the first 48 h of life. The distribution of the placental pathologies included infarction (45%), maternal vasculopathy (26%), meconium staining (16%), histologic chorioamnionitis (13%), calcification (9%) and funisitis (3%). Because of their prevalence, placental infarction, maternal vasculopathy and placental calcifications were chosen to compare with the presence or absence of neutropenia and thrombocytopenia, total NRBCs and Hct values. Although more prevalent than placental calcifications, histologic chorioamnionitis and meconium staining were not considered in relationship to neonatal parameters as they are common comorbid factors for many other conditions.
Infants with neutropenia were of lower gestation, lower birthweight and more likely to be SGA compared with infants without neutropenia (Table 1) . There were no differences in the occurrence of placental infarction, placental vasculopathy or placental weight in infants with neutropenia compared with those without neutropenia. After multivariable analysis to control for potential confounding variables including gestational age, birthweight, race, SGA, multiple gestation, use of prenatal steroids and placental pathology, only gestational age (odds ratio of 1.3, 95% CI 1.1 to 1.6) and SGA (odds ratio of 4.2 (CI 1.3 to 13.5) remained associated with neutropenia. Neither placental weight nor the presence of placental infarction, calcification or vasculopathy was associated with neonatal neutropenia. Similarly, infants with thrombocytopenia were also found to be of lower gestational age, birthweight and more likely to be SGA. Again, there were no differences found in the occurrence of placental infarction, placental vasculopathy, calcification or placental weight when compared with infants without thrombocytopenia ( Table 2) . After multivariable analysis to control for potential confounding variables including gestational age, birthweight, SGA, multiple gestation, use of prenatal steroids and placental pathology, only gestational age (OR 1.2, 95% CI 1.0 to 1.4) and SGA (OR 4.2, CI 1.6 to 11) were associated with an increased odds of thrombocytopenia. Neither placental weight nor the presence of placental infarction, calcification, or vasculopathy was associated with neonatal neutropenia.
Thirty-eight percent of the infants were both neutropenic and thrombocytopenic. Of the infants without neutropenia, 20% were thrombocytopenic (P ¼ 0.3). In the infants with both neutropenia and thrombocytopenia 27% had placental infarctions, 18% had placental calcifications and 33% had placental vasculopathies.
No association was found between the presence of placental infarction, placental calcification or placental vasculopathies and Hct or NRBCs in the first 48 h of life (Tables 3 and 4) .
Discussion
In our population of VLBW infants born to mothers with preeclampsia, placental pathology was common. Despite the common occurrence of placental infarction and maternal vasculopathy, these findings were not associated with neonatal neutropenia or thrombocytopenia. After controlling for potential confounding variables such as lower birthweight, lower gestational age and/or SGA remained associated with increased odds of neonatal thrombocytopenia and neutropenia.
Preeclampsia continues to be an increasing problem associated with preterm birth and is known to be a common cause of neonatal neutropenia and thrombocytopenia. 1 The incidence of neutropenia is reported as high as 49% in pregnancy-induced hypertension exposed infants.
2 Consistent with our findings, neutropenia severity has been correlated with the severity of growth restriction and prematurity. 4 Kinetic investigations have suggested that neutropenia in infants born to mothers with preeclampsia is secondary to decreased production of WBCs as evidenced by decreased circulating, marginated, storage, progenitor and proliferative neutrophils. 2 Our data suggest that the decreased production of WBCs is not associated with histologic changes in the placenta including placental infarction or vasculopathy.
Early onset of neonatal thrombocytopenia is most commonly observed secondary to placental insufficiency with maternal hypertension being the largest risk factor. 17 Burrows and colleagues found that in hypertensive mothers, preterm birth was the major risk factor for neonatal thrombocytopenia. Term infants exposed to maternal hypertension had the same incidence of thrombocytopenia as the control population. 5 This finding suggests that hypertension effects may be of a different pathophysiologic pathway in term versus preterm infants. This observation is consistent with our finding of thrombocytopenia associated with lower gestational age in infants born to mothers with preeclampsia.
Preelcampsia is known to have associated placental pathology. Redline et al. 18 evaluated 609 placentas and found most placental lesions before 37-week gestation, specifically maternal vasculopathy, villitis and increased intervillous fibrin were increased in pregnancies complicated by hypertension. Soma et al. described that there are many microscopic findings common in the Data shows total number of NRBC/mm 3 . All data are presented as mean with 95% CI. P-value represents repeated measures ANOVA. Abbreviations: ANOVA, analysis of variance; NRBC, nucleated red blood cells.
placentas of hypertensive patients. These lesions included increased syncytial knots, villi hypovascularity, cytotrophoblastic proliferation, with thickened basement membranes, atherosis of the spiral arteries and narrowed fetal capillaries. 10 Different placental histopathologies have been associated with specific clinical features of preterm preeclampsia. Severe maternal proteinuria has been related to placental chronic inflammation, whereas lower maternal antepartum Plt counts were related to placental abruption and infarction. In addition, lower birthweight percentiles and lighter placentas were directly associated with uteroplacental vascular lesions. 19 Ghidini's 11 prospective study used a scoring system based on severity and extent of placental vascular and villous lesions and found that the clinical diagnosis of preeclampsia increased with progressive uteroplacental impairment. The lesions defined in Ghidini's study were analyzed for more specific lesions than is typically found in a standard placental pathology report and could not be applied to this study. Kush et al. 20 evaluated the relationship between umbilical artery end diastolic velocity in growth-restricted fetuses and associated hematologic alterations that were proportional to the degree of placental dysfunction, which was able to be predicted by fetal Doppler measurements. Absent end diastolic umbilical artery velocity was also associated with increased NRBC counts. 21 We were unable to show any association between placental pathology and neonatal hematologic abnormalities. There are a number of potential explanations for this finding and our data should be interpreted with caution. There may be no causal effect of placental pathology on neonatal neutropenia or thrombocytopenia. Alternatively, placental pathology may still be associated with the hematologic effects of maternal preeclampsia; however, the placental pathologies leading to neutropenia or thrombocytopenia may be different than those selected in this study. As our investigation was retrospective, we may have missed some frequent subtle placental pathologies, which may not have been routinely reported on clinical pathology reports. Placental analysis is relatively subjective with less than 5% of the tissue examined histologically according to the Placental Pathology Practice Guideline Development Task Force. 13 Findings such as increased amounts of syncytial knots and necrosis, thickened trophoblastic basement membranes and narrowed fetal capillaries as previously discussed findings in preeclamptic placentas tend to be subtle variations that are not typically commented upon in a routine placental pathology analysis. In addition, some frequent findings in preeclampsia, such as meconium staining may be too nonspecific to draw reliable conclusions from. It may be of benefit to form a prospective study designed to have evaluations for specific placental lesions and then analyze whether these lesions have direct hematologic correlation.
It is plausible that the placental pathologies we investigated were not necessarily associated with physiologic placental insufficiency. Perhaps, other placental factors may be the causative agents of neonatal hematologic aberrations. Histologic chorioamnionitis, common in preterm birth, has been associated with increased levels of cord blood cytokines and increase intracranial hemorrhage in neonates. 22, 23 Inflammation may have a contributing role and warrant further investigation with regard to preeclampsia and neonatal neutropenia and thrombocytopenia. The number of infants born to mothers with histologic chorioamnionitis in our study cohort was too small to make a meaningful association. Furthermore, histologic chorioamnionitis may have been associated with other comorbidities such as premature labor. Other limitations of our study may include the possibility of inter-observer variance and lack of consensus on the diagnosis of placental lesions. However, adhering to methodical practice guidelines at a single institution and standard definitions likely limited this variablity.
In conclusion, in our population of VLBW infants born to mothers with preeclampsia, placental pathology was common. There was, however, no association of placental infarction or vasculopathy with neonatal neutropenia, thrombocytopenia or other hematologic parameters. Our data suggest that the neonatal hematologic effects of maternal preeclampsia, if related to the placenta, are associated with factors other than placental histology. 
